-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Anbio Biotechnology quarterly Assets history and change rate from Q4 2023 to Q4 2024.
- Anbio Biotechnology Assets for the quarter ending 31 Dec 2024 was $18.9M, a 19.7% increase year-over-year.